First Longevity Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
First Longevity Ltd - overview
Established
1997
Location
London, -, UK
Primary Industry
Biotechnology
About
First Longevity Ltd is a health-focused investment platform connecting investors with innovative projects in the longevity and wellness sectors, facilitating funding for transformative health initiatives. Founded in 1997 and headquartered in London, UK, First Longevity Ltd specializes in linking investors with health-related opportunities. The company operates under the leadership of Phil Newman, who has a background in advancing health technology solutions. In November 2021, the firm successfully raised USD 2.
5 mn in venture funding led by Xploration Capital. Through its platform, First Longevity Ltd connects individuals and groups seeking investment capital with potential investors. The service aims to address the funding needs in the health sector, particularly in longevity and wellness initiatives. Their clientele includes health technology startups and wellness companies across North America, Europe, and parts of Asia, where demand for health innovations is increasing.
First Longevity Ltd generates revenue primarily through transaction fees applied when successful matches are made between investors and health enterprises on their platform. The fee is based on a percentage of the investment amount, facilitating a B2B model focused on health and wellness sectors. Following the USD 2. 5 mn funding raised in November 2021, First Longevity Ltd plans to enhance its platform capabilities and develop new products aimed at improving investor engagement.
The firm is also targeting expansion into emerging markets in Asia and South America by the end of 2023, aiming to tap into the increasing demand for health innovations in these regions.
Current Investors
Xploration Capital
Primary Industry
Biotechnology
Sub Industries
Biotechnology
Website
www.longevity.technology
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
First Longevity Ltd - financials
| Fiscal Year Ended | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|
| Revenue (USD) | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - |
| EBITDA (USD) | - | - | - | - |
| Operating Income (USD) | - | - | - | - |
| Operating Margin | - | - | - | - |
| % EBITDA Margin | - | - | - | - |
| NET Income (USD) | (41,318) | - | - | - |
| % Net Margin | - | - | - | - |
First Longevity Ltd - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.